WHO ICTRP trial

A Clinical Trial to see effect of Bacillus subtilis HU58 and Bacillus coagulans…

CTRI/2021/10/037398 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2021/10/037398
Public title A Clinical Trial to see effect of Bacillus subtilis HU58 and Bacillus coagulans SC208 syrup in treatment of acute diarrhoea in children
Scientific title A Multicentre, Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Trial to Evaluate Efficacy and Safety of Bacillus subtilis HU58 + Bacillus coagulans SC208 Syrup in Treatment of Acute Diarrhoea in Children.
Primary sponsor Synergia Life Sciences Pvt Ltd
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: R197- Diarrhea, unspecified
Interventions Intervention1: Probiotic Bacillus subtilis HU58 and Bacillus coagulans SC208 Syrup: 5 ml of syrup to be given once a day orally for 7 days The dose will be increased to twice daily at visit 3 (Day 3) as per Investigators discretion based on…
Registration date Oct 20, 2021
Target size 64
Secondary IDs BCR-SYN-001 Version 2.0 Dated 28 Sep 2021
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations